✦ LIBER ✦

COX-2 inhibition and prevention of cancer

✍ Scribed by Karl-Erik Giercksky

Book ID: 111719839
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 136 KB
Volume: 15
Category: Article
ISSN: 1521-6918
DOI: 10.1053/bega.2001.0237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is COX-2 inhibition a panacea for cancer

Is COX-2 inhibition a panacea for cancer prevention?

✍ Harri Vainio 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 46 KB

The epidemiologic evidence and rodent studies suggest strongly that nonselective inhibitors of cyclooxygenase (COX) enzymes such as aspirin, inhibiting both COX-1 and COX-2 isoforms, reduce the incidence of and mortality from intestinal tumors. Genetically manipulated animals show that both Cox-1 an

COX-2 Blockade in Cancer Prevention and

COX-2 Blockade in Cancer Prevention and Therapy,

✍ Joanne van Ryn; Jacques van Meel 📂 Article 📅 2003 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 34 KB

COX-2 Inhibitors for the Prevention of B

COX-2 Inhibitors for the Prevention of Breast Cancer

✍ Louise R. Howe; Andrew J. Dannenberg 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 311 KB

Cox-2 inhibition for the treatment of co

Cox-2 inhibition for the treatment of colon cancer

✍ Carlos Becerra 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 30 KB

Aguilar and associates state that the dose of rofecoxib used in our clinical study is insufficient based on experiments in OFA rats whereby the best dose to reduce or prevent colorectal cancer is at least 2.5 mg/kg/day. This dose would represent 3-4-fold increase in the dose given to patients in the

COX-2 and colon cancer

✍ M. M. Taketo 📂 Article 📅 1998 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 167 KB

Prevention of colorectal cancer through

Prevention of colorectal cancer through the use of COX-2 selective inhibitors

✍ Richard M. Peek 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 204 KB